Moleculin Biotech (MBRX) Prepaid Assets (2016 - 2026)
Moleculin Biotech (MBRX) posted quarterly Prepaid Assets of $512000.0 for Q4 2025, down 7.58% year-over-year from $554000.0 in Q4 2024, and down 34.86% quarter-over-quarter from $786000.0 in Q3 2025.
Moleculin Biotech (MBRX) Prepaid Assets (2016 - 2026) Analysis & Trends
Moleculin Biotech's Prepaid Assets history runs 10 years deep, the most recent figure standing at $512000.0 for Q4 2025.
- In Q4 2025, Prepaid Assets fell 7.58% year-over-year to $512000.0; the TTM figure through Dec 2025 stood at $512000.0 (down 7.58% YoY), while the FY2025 annual figure was $512000.0, down 7.58% from the prior year.
- Prepaid Assets for Q4 2025 stood at $512000.0, down from $786000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $3.3 million in Q2 2022, with the low at $293000.0 in Q1 2025.
- The 5-year median for Prepaid Assets is $2.0 million (2021), against an average of $1.8 million.
- The sharpest annual moves came in 2021 and 2025: Prepaid Assets surged 434.4% in 2021, then slumped 86.26% in 2025.
- Moleculin Biotech's Prepaid Assets stood at $589000.0 in 2021, then jumped by 316.13% to $2.5 million in 2022, then climbed by 11.1% to $2.7 million in 2023, then slumped by 79.65% to $554000.0 in 2024, then fell by 7.58% to $512000.0 in 2025.
- Business Quant data shows MBRX's Prepaid Assets at $512000.0 in Q4 2025, $786000.0 in Q3 2025, and $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moleculin Biotech | 3.37 Mn | 3.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.46 Mn |
| Dec 31, 2025 | 512,000.00 |
| Sep 30, 2025 | 786,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 293,000.00 |
| Dec 31, 2024 | 554,000.00 |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Mar 31, 2024 | 2.13 Mn |
| Dec 31, 2023 | 2.72 Mn |
| Sep 30, 2023 | 3.02 Mn |
| Jun 30, 2023 | 3.21 Mn |
| Mar 31, 2023 | 2.02 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 938,000.00 |
| Jun 30, 2022 | 3.32 Mn |
| Mar 31, 2022 | 1.16 Mn |
| Dec 31, 2021 | 589,000.00 |
| Sep 30, 2021 | 1.89 Mn |
| Jun 30, 2021 | 2.33 Mn |